
Sensei Biotherapeutics Inc is a clinical-stage immunotherapy company. It is engaged in the discovery and development of next-generation therapies with an initial focus on treatments for cancer. The company's ImmunoPhage platform is a powerful, self-adjuvanted and highly differentiated immunotherapy ... Sensei Biotherapeutics Inc is a clinical-stage immunotherapy company. It is engaged in the discovery and development of next-generation therapies with an initial focus on treatments for cancer. The company's ImmunoPhage platform is a powerful, self-adjuvanted and highly differentiated immunotherapy approach that is designed to utilize bacteriophage to induce a robust, focused, and coordinated innate and adaptive immune response. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0147 | -4.25224182817 | 0.3457 | 0.359 | 0.3 | 119447 | 0.33006705 | CS |
4 | -0.033 | -9.06593406593 | 0.364 | 0.4392 | 0.3 | 116818 | 0.3665144 | CS |
12 | -0.145 | -30.4621848739 | 0.476 | 0.7595 | 0.25 | 2777579 | 0.49312373 | CS |
26 | -0.1602 | -32.6140065147 | 0.4912 | 0.7595 | 0.25 | 1572996 | 0.49574863 | CS |
52 | -1.139 | -77.4829931973 | 1.47 | 1.5486 | 0.25 | 899629 | 0.52058682 | CS |
156 | -1.249 | -79.0506329114 | 1.58 | 2.39 | 0.25 | 348734 | 0.65329171 | CS |
260 | -24.369 | -98.6599190283 | 24.7 | 26.38 | 0.25 | 280831 | 2.03886225 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.